Grant: Discovery Grants Program - Individual
Laurentian University of Sudbury
$36,000.00
Transcriptional control of cardiac fibroblast development
FY 2020-21
Summary
Being the first organ to form and function, the heart needs to grow and adapt to the changing needs of the organism throughout its life. Cardiac fibroblasts help define the structural and mechanical properties of the heart by secreting and remodeling the extracellular matrix. The differentiation of cardiac fibroblasts is tuned to respond to mechanical load, however, we have a limited understanding of the molecular mechanism responsible for this effect. Our research program will examine the role of the vitamin A metabolite, retinoic acid, in the mechano-transduction pathways that influence the development of cardiac fibroblasts. Retinoic acid, a ligand of nuclear hormone receptors, controls gene expression, and is an important signaling molecule in guiding heart development. During late gestation, retinoic acid synthesis is confined to the epicardium, a mesothelial layer that covers the heart. Our recent studies demonstrate that epicardial retinoic acid signaling plays critical roles in controlling coronary vascular development and the formation of vascular smooth muscle and fibroblast precursor cells. Preliminary studies also suggest that epicardial retinoic acid signaling is influenced by mechanical stress via the conserved Yap/Taz pathway. Our studies will test the novel hypothesis, that retinoic acid signaling controls cardiac fibroblast differentiation in response to mechanical stress. Through in vivo imaging of avian embryonic models, we will first establish the dynamics and patterns of activation of Yap/Taz signaling during epicardial development. Using avian embryos and cell culture models we will next examine the effect of mechanical stress on the activation of Yap/Taz and retinoic acid-signaling in epicardial cells. We will extend these findings to determine the role of retinoic acid signaling in the development of cardiac fibroblasts using embryonic rodent models of altered levels of retinoic acid previously established by our lab. The studies proposed will provide an understanding of a fundamental process that governs the mechanical properties of the developing heart and will provide a new direction to promote our overarching goal of defining the role of vitamin A, and other diet-derived bioactive metabolites in guiding embryonic development.
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2019-04002
Name nom
Moise, Alexander Radu
Department département
Faculty of Medicine
Organization id
26
Institution établissement
Laurentian University of Sudbury
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2019
Award amount
36000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5105
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell differentiation
Research subject fr
Différenciation cellulaire
Installment
inst:2-5
Partie
4
Nb partie
5
Application title
Transcriptional control of cardiac fibroblast development
Keyword
NSERC
Application summary
Being the first organ to form and function, the heart needs to grow and adapt to the changing needs of the organism throughout its life. Cardiac fibroblasts help define the structural and mechanical properties of the heart by secreting and remodeling the extracellular matrix. The differentiation of cardiac fibroblasts is tuned to respond to mechanical load, however, we have a limited understanding of the molecular mechanism responsible for this effect. Our research program will examine the role of the vitamin A metabolite, retinoic acid, in the mechano-transduction pathways that influence the development of cardiac fibroblasts. Retinoic acid, a ligand of nuclear hormone receptors, controls gene expression, and is an important signaling molecule in guiding heart development. During late gestation, retinoic acid synthesis is confined to the epicardium, a mesothelial layer that covers the heart. Our recent studies demonstrate that epicardial retinoic acid signaling plays critical roles in controlling coronary vascular development and the formation of vascular smooth muscle and fibroblast precursor cells. Preliminary studies also suggest that epicardial retinoic acid signaling is influenced by mechanical stress via the conserved Yap/Taz pathway. Our studies will test the novel hypothesis, that retinoic acid signaling controls cardiac fibroblast differentiation in response to mechanical stress. Through in vivo imaging of avian embryonic models, we will first establish the dynamics and patterns of activation of Yap/Taz signaling during epicardial development. Using avian embryos and cell culture models we will next examine the effect of mechanical stress on the activation of Yap/Taz and retinoic acid-signaling in epicardial cells. We will extend these findings to determine the role of retinoic acid signaling in the development of cardiac fibroblasts using embryonic rodent models of altered levels of retinoic acid previously established by our lab. The studies proposed will provide an understanding of a fundamental process that governs the mechanical properties of the developing heart and will provide a new direction to promote our overarching goal of defining the role of vitamin A, and other diet-derived bioactive metabolites in guiding embryonic development.